Rapid High-Throughput Method for Investigating Physiological Regulation of Neutrophil Extracellular Trap Formation.

Extracellular Traps Immunity Neutrophils Sepsis innate

Journal

Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508

Informations de publication

Date de publication:
10 Jun 2024
Historique:
received: 08 01 2024
revised: 01 05 2024
accepted: 14 05 2024
medline: 13 6 2024
pubmed: 13 6 2024
entrez: 12 6 2024
Statut: aheadofprint

Résumé

Neutrophils, the most abundant white blood cells in humans, play pivotal roles in innate immunity, rapidly migrating to sites of infection and inflammation to phagocytose, neutralize, and eliminate invading pathogens. Neutrophil Extracellular Trap (NET) formation is increasingly recognized as an essential rapid innate immune response, but when dysregulated contributes to pathogenesis of sepsis and immunothrombotic disease. Current NETosis models are limited, routinely employing non-physiological triggers that can bypass natural NET regulatory pathways. Models utilizing isolated neutrophils and immortalized cell lines, do not reflect the complex biology underlying neutrophil activation and NETosis, that occurs in whole-blood. To our knowledge, we report the first human ex-vivo model utilizing naturally occurring molecules to induce NETosis in whole blood. This approach could be used for drug screening and, importantly, inadvertent activators of NETosis. Here we describe a novel, high-throughput ex-vivo whole blood induced NETosis model using combinatorial pooling of native NETosis inducing factors in a more biologically relevant Synthetic-Sepsis™ model. We found different combinations of factors evoked distinct neutrophil responses in the rate of NET generation and/or magnitude of NETosis. Despite inter-donor variability, similar sets of pro-inflammatory molecules induced consistent responses across donors. We found at least three biological triggers, were necessary to induce NETosis in our system including either TNF-α or LT-α. These findings emphasize the importance of investigating neutrophil physiology in a biologically relevant context to enable a better understanding of disease pathology, risk factors, and therapeutic targets, potentially, providing novel strategies for disease intervention and treatment.

Sections du résumé

BACKGROUND BACKGROUND
Neutrophils, the most abundant white blood cells in humans, play pivotal roles in innate immunity, rapidly migrating to sites of infection and inflammation to phagocytose, neutralize, and eliminate invading pathogens. Neutrophil Extracellular Trap (NET) formation is increasingly recognized as an essential rapid innate immune response, but when dysregulated contributes to pathogenesis of sepsis and immunothrombotic disease.
OBJECTIVES OBJECTIVE
Current NETosis models are limited, routinely employing non-physiological triggers that can bypass natural NET regulatory pathways. Models utilizing isolated neutrophils and immortalized cell lines, do not reflect the complex biology underlying neutrophil activation and NETosis, that occurs in whole-blood. To our knowledge, we report the first human ex-vivo model utilizing naturally occurring molecules to induce NETosis in whole blood. This approach could be used for drug screening and, importantly, inadvertent activators of NETosis.
METHODS METHODS
Here we describe a novel, high-throughput ex-vivo whole blood induced NETosis model using combinatorial pooling of native NETosis inducing factors in a more biologically relevant Synthetic-Sepsis™ model.
RESULTS RESULTS
We found different combinations of factors evoked distinct neutrophil responses in the rate of NET generation and/or magnitude of NETosis. Despite inter-donor variability, similar sets of pro-inflammatory molecules induced consistent responses across donors. We found at least three biological triggers, were necessary to induce NETosis in our system including either TNF-α or LT-α.
CONCLUSION CONCLUSIONS
These findings emphasize the importance of investigating neutrophil physiology in a biologically relevant context to enable a better understanding of disease pathology, risk factors, and therapeutic targets, potentially, providing novel strategies for disease intervention and treatment.

Identifiants

pubmed: 38866247
pii: S1538-7836(24)00320-9
doi: 10.1016/j.jtha.2024.05.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Kieran Zukas (K)

Volition America, 6086 Corte Del Cedro Carlsbad, CA 92011.

Justin Cayford (J)

Volition America, 6086 Corte Del Cedro Carlsbad, CA 92011.

Finley Serneo (F)

Volition America, 6086 Corte Del Cedro Carlsbad, CA 92011.

Brandi Atteberry (B)

Volition America, 6086 Corte Del Cedro Carlsbad, CA 92011.

Andrew Retter (A)

Guys and St. Thomas NHS Foundation Trust, Lambeth, London, United Kingdom, SE1 7EH.

Mark Eccleston (M)

Volition America, 6086 Corte Del Cedro Carlsbad, CA 92011.

Theresa K Kelly (TK)

Volition America, 6086 Corte Del Cedro Carlsbad, CA 92011. Electronic address: t.kelly@volition.com.

Classifications MeSH